BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Balasubramaniam S, Duley JA, Christodoulou J. Inborn errors of pyrimidine metabolism: clinical update and therapy. J Inherit Metab Dis 2014;37:687-98. [PMID: 25030255 DOI: 10.1007/s10545-014-9742-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Di Meo I, Lamperti C, Tiranti V. Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approaches. EMBO Mol Med. 2015;7:1257-1266. [PMID: 26194912 DOI: 10.15252/emmm.201505040] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
2 Puusepp S, Reinson K, Pajusalu S, van Kuilenburg ABP, Dobritzsch D, Roelofsen J, Stenzel W, Õunap K. Atypical presentation of Arts syndrome due to a novel hemizygous loss-of-function variant in the PRPS1 gene. Mol Genet Metab Rep 2020;25:100677. [PMID: 33294372 DOI: 10.1016/j.ymgmr.2020.100677] [Reference Citation Analysis]
3 Pacitti D, Levene M, Garone C, Nirmalananthan N, Bax BE. Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far. Front Genet 2018;9:669. [PMID: 30627136 DOI: 10.3389/fgene.2018.00669] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
4 Monostori P, Klinke G, Hauke J, Richter S, Bierau J, Garbade SF, Hoffmann GF, Langhans CD, Haas D, Okun JG. Extended diagnosis of purine and pyrimidine disorders from urine: LC MS/MS assay development and clinical validation. PLoS One 2019;14:e0212458. [PMID: 30817767 DOI: 10.1371/journal.pone.0212458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Yarahmadi SG, Morovvati S. CAD gene and early infantile epileptic encephalopathy-50; three Iranian deceased patients and a novel mutation: case report. BMC Pediatr 2022;22. [DOI: 10.1186/s12887-022-03195-4] [Reference Citation Analysis]
6 Brasil S, Pascoal C, Francisco R, Marques-da-Silva D, Andreotti G, Videira PA, Morava E, Jaeken J, Dos Reis Ferreira V. CDG Therapies: From Bench to Bedside. Int J Mol Sci 2018;19:E1304. [PMID: 29702557 DOI: 10.3390/ijms19051304] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 11.8] [Reference Citation Analysis]
7 Al Absi HS, Sacharow S, Al Zein N, Al Shamsi A, Al Teneiji A. Hereditary orotic aciduria (HOA): A novel uridine-5-monophosphate synthase (UMPS) mutation. Mol Genet Metab Rep 2021;26:100703. [PMID: 33489760 DOI: 10.1016/j.ymgmr.2020.100703] [Reference Citation Analysis]
8 Ipata PL, Pesi R. Nucleoside recycling in the brain and the nucleosidome: a complex metabolic and molecular cross-talk between the extracellular nucleotide cascade system and the intracellular nucleoside salvage. Metabolomics 2016;12. [DOI: 10.1007/s11306-015-0931-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
9 Marie S, van den Berghe G, Vincent M. Disorders of Purine and Pyrimidine Metabolism. In: Saudubray J, Baumgartner MR, Walter J, editors. Inborn Metabolic Diseases. Berlin: Springer Berlin Heidelberg; 2016. pp. 495-513. [DOI: 10.1007/978-3-662-49771-5_35] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Jurecka A, Tylki-szymanska A. Inborn errors of purine and pyrimidine metabolism: A guide to diagnosis. Molecular Genetics and Metabolism 2022. [DOI: 10.1016/j.ymgme.2022.02.007] [Reference Citation Analysis]
11 Sun Q. Urine Pyrimidine Metabolite Determination by HPLC Tandem Mass Spectrometry. In: Garg U, editor. Clinical Applications of Mass Spectrometry in Biomolecular Analysis. New York: Springer; 2016. pp. 237-42. [DOI: 10.1007/978-1-4939-3182-8_25] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
12 Löffler M, Carrey EA, Zameitat E. New perspectives on the roles of pyrimidines in the central nervous system. Nucleosides Nucleotides Nucleic Acids 2018;37:290-306. [PMID: 29693489 DOI: 10.1080/15257770.2018.1453076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wortmann SB, Chen MA, Colombo R, Pontoglio A, Alhaddad B, Botto LD, Yuzyuk T, Coughlin CR, Descartes M, Grűnewald S, Maranda B, Mills PB, Pitt J, Potente C, Rodenburg R, Kluijtmans LA, Sampath S, Pai EF, Wevers RA, Tiller GE; additional individual contributors. Mild orotic aciduria in UMPS heterozygotes: a metabolic finding without clinical consequences. J Inherit Metab Dis 2017;40:423-31. [PMID: 28205048 DOI: 10.1007/s10545-017-0015-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
14 Löffler M, Carrey EA, Zameitat E. Orotic Acid, More Than Just an Intermediate of Pyrimidine de novo Synthesis. Journal of Genetics and Genomics 2015;42:207-19. [DOI: 10.1016/j.jgg.2015.04.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
15 Gregg XT, Prchal JT. Red Blood Cell Enzymopathies. Hematology. Elsevier; 2018. pp. 616-25. [DOI: 10.1016/b978-0-323-35762-3.00044-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Herink MC, Irwin AN, Zumach GM. FDA Breakthrough Therapy Designation: Evaluating the Quality of the Evidence behind the Drug Approvals. Pharmacotherapy 2018;38:967-80. [PMID: 30043413 DOI: 10.1002/phar.2167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Huazano-García A, Silva-Adame MB, Vázquez-Martínez J, Gastelum-Arellanez A, Sánchez-Segura L, López MG. Highly Branched Neo-Fructans (Agavins) Attenuate Metabolic Endotoxemia and Low-Grade Inflammation in Association with Gut Microbiota Modulation on High-Fat Diet-Fed Mice. Foods 2020;9:E1792. [PMID: 33287102 DOI: 10.3390/foods9121792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Garavito MF, Narváez-Ortiz HY, Zimmermann BH. Pyrimidine Metabolism: Dynamic and Versatile Pathways in Pathogens and Cellular Development. J Genet Genomics 2015;42:195-205. [PMID: 26059768 DOI: 10.1016/j.jgg.2015.04.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 6.6] [Reference Citation Analysis]
19 Sheng XQ, Wang YC. Novel two-step derivation method for the synchronous analysis of inherited metabolic disorders using urine. Exp Ther Med 2017;13:1961-8. [PMID: 28565794 DOI: 10.3892/etm.2017.4167] [Reference Citation Analysis]
20 Koch J, Mayr JA, Alhaddad B, Rauscher C, Bierau J, Kovacs-Nagy R, Coene KL, Bader I, Holzhacker M, Prokisch H, Venselaar H, Wevers RA, Distelmaier F, Polster T, Leiz S, Betzler C, Strom TM, Sperl W, Meitinger T, Wortmann SB, Haack TB. CAD mutations and uridine-responsive epileptic encephalopathy. Brain 2017;140:279-86. [PMID: 28007989 DOI: 10.1093/brain/aww300] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 10.0] [Reference Citation Analysis]
21 Zschocke J. Erbliche Stoffwechselkrankheiten – eine Übersicht. Medizinische Genetik 2015;27:268-75. [DOI: 10.1007/s11825-015-0062-2] [Reference Citation Analysis]
22 Destanoğlu O, Zeydanlı D, Cansever MŞ, Yılmaz GG. Ion chromatographic method for the determination of orotic acid in urine. Analytical Biochemistry 2018;563:9-14. [DOI: 10.1016/j.ab.2018.09.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Pérez-Torras S, Mata-Ventosa A, Drögemöller B, Tarailo-Graovac M, Meijer J, Meinsma R, van Cruchten AG, Kulik W, Viel-Oliva A, Bidon-Chanal A, Ross CJ, Wassermann WW, van Karnebeek CDM, Pastor-Anglada M, van Kuilenburg ABP. Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure. Biochim Biophys Acta Mol Basis Dis 2019;1865:1182-91. [PMID: 30658162 DOI: 10.1016/j.bbadis.2019.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Fumagalli M, Lecca D, Abbracchio MP, Ceruti S. Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases. Front Pharmacol 2017;8:941. [PMID: 29375373 DOI: 10.3389/fphar.2017.00941] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
25 Löffler M, Carrey EA, Zameitat E. Orotate (orotic acid): An essential and versatile molecule. Nucleosides Nucleotides Nucleic Acids 2016;35:566-77. [PMID: 27906623 DOI: 10.1080/15257770.2016.1147580] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]